| Active Ingredient | Ceftazidime & Avibactam |
| Strength | 2 gm & 0.5 gm |
| Dosage Form | Injection |
| Route of Administration | Intravenous (IV) |
| Pack Details | Single-dose Vial |
Indications:
1. Complicated UTI including Pyelonephritis
2. Hospital Acquired Pneumonia ( HAP) & Ventilator Associated Pneumonia ( VAP)
3. Infections caused by Multidrug-resistant (MDR) Gram negative bacteria
4. Complicated Intra Abdominal Infections ( cIAI) with metronidazole
Bacteramia associated with or suspected to be associated with cUTI, HAP/VAP or cIAI
| Active Ingredient | Aztreonam USP |
| Strength | 1 g per vial |
| Dosage Form | Injection |
| Route of Administration | Intravenous (IV) / Intramuscular (IM) |
| Pack Details | Single-dose Vial |
Therapeutic Indications:
1. Complicated & Non Complicated UTI including pyelonephritis and cystitis (initial and
recurrent)
2. Lower Respiratory Tract Infections including pneumonia and bronchitis
3. Septicemia
4. Skin and Skin-Structure Infections including those associated with postoperative wounds,
ulcers and burns
5. Intra-abdominal Infections including peritonitis
Gynecologic Infections including endometritis and pelvic cellulitis